The largest database of trusted experimental protocols

M mlv reverse transcriptase first strand kit

Manufactured by Thermo Fisher Scientific
Sourced in United States

The M-MLV reverse transcriptase First-Strand Kit is a laboratory product used for the conversion of RNA to complementary DNA (cDNA). The kit contains the M-MLV reverse transcriptase enzyme, which catalyzes the synthesis of single-stranded cDNA from an RNA template.

Automatically generated - may contain errors

3 protocols using m mlv reverse transcriptase first strand kit

1

Quantitative Real-Time PCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
After being treated with different compounds for 24 h, cells were harvested and washed with ice-cold phosphate buffer. Total RNA was prepared using trizol reagent (TaKaRa, Japan) according to the manufacturer's instructions. The quantity and purity of the RNA were assessed by measuring the absorbance at 260 and 280 nm. The cDNA was synthesized from total RNA (2 μg) with oligo (dT) 20 primers using an M-MLV reverse transcriptase First-Strand Kit (Invitrogen Corp., Carlsbad, CA, USA) according to the manufacturer's instructions. Quantitative real-time polymerase chain reaction (RT-PCR) was performed using SYBR Green master mix, and the detection of mRNA was analyzed using an ABI StepOne RT-PCR System (Applied Biosystems, Foster City, CA, USA). Primer sequences for the reference gene β-actin and the genes of interest were shown in Table 1. Typical profile times used were the initial step, 95°C for 10 min followed by a second step at 95°C for 15 s and 60°C for 30 s for 40 cycles with a melting curve analysis. The level of target mRNA was normalized to the level of the β-actin and compared with the control. Data were analyzed using theΔΔ CT method.
+ Open protocol
+ Expand
2

RNA Extraction and RT-PCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted from cells using an RNeasy Total RNA system (Qiagen, Inc, Valencia, CA, USA) according to the manufacturer's protocol. The quantity and purity of the RNA were assessed by measuring the absorbance at 260 and 280 nm. The cDNA was synthesized from total RNA (2 µg) with oligo (dT) primers using an M-MLV reverse transcriptase first strand kit (Invitrogen; Thermo Fisher Scientific, Inc.). A 25 µl PCR reaction contained 4 µl cDNA, 2.5 µl buffer, 1 µl forward primer, 1 µl reverse primer, 1 µl dNTP, 1 µl Taq DNA polymerase and 14.5 µl DEPC water. The primers used were as follows: Octamer-binding transcription factor-4 (OCT-4), forward 5′-TGGGCTAGAGAAGGATGTGG-3′ and reverse 5′-CTGGGAAAGGTGTCCCTGTA-3′; sex determining region Y-box 2 (SOX-2), forward 5′-GAACGCCTTCATGGTATGGT-3′ and reverse 5′-TCTCGGTCTCGGACAAAAGT-3′; GAPDH, forward 5′-GGTTGTCTCCTGCGACTTCA-3′ and reverse 5′-TGGTCCAGGGTTTCTTACTCC-3′. The PCR reaction conditions were as follows: 94°C for 5 min, followed by 30 cycles of 94°C for 40 sec, 61°C for 30 sec and 72°C for 10 min. The PCR products were analyzed on a 2% agarose gel with ethidium bromide. The gel images were analyzed using Image-Pro plus 6.0 software (Media Cybernetics, Inc. Rockville, MD, USA).
+ Open protocol
+ Expand
3

Quantitative RNA Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from cells using TRIzol reagent (Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. cDNA was synthesized using total RNA (1 µg) with random primers and the MMLV reverse transcriptase First Strand kit at 37°C for 15 min, followed by 85°C for 5 sec and storage at 4°C (Invitrogen; Thermo Fisher Scientific, Inc.). qPCR was performed using the SYBR®Premix Ex Taqkit (Takara Bio, Inc., Otsu, Japan). The thermocycling conditions were as follows: 95°C for 10 min, followed by 40 cycles of 95°C for 10 sec and 60°C for 30 sec. The following primers were used: GAPDH forward, 5′-CGGAGTCAACGGATTTGGTCGTAT-3′ and reverse, 5′-AGCCTTCTCCATGGTGGTGAAGAC-3′; kidney injury molecule 1 (KIM-1) forward, 5′-GACAACGAGCATTCCAACAA-3′ and reverse, 5′-GCTGAGGTGAAGATGGTGAAG-3′; neutrophil gelatinase-associated lipocalin (NGAL) forward, 5′-ACAAAGACCCGCAAAAGATG-3′ and reverse, 5′-GCAACCTGGAACAAAAGTCC-3′. All data was normalized using the internal control GAPDH. Fold change were quantified using the 2−∆∆Cq method (25 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!